Study
“LMI” Tau Detection Study
The purpose of this study is to investigate the effectiveness and safety of a new injection—given in conjunction with a PET scan—to help detect tau protein in the brain. Tau protein is a key feature of Alzheimer’s disease that affects the nervous system and may occur well before clinical signs of the disease. Early detection could help with the diagnostic process, as well as the treatment of, Alzheimer’s disease.
Location:
- Winter Park
Who is eligible?
You may qualify for this study if:
- 50+ years of age.
- A projected life expectancy of less than or equal to 1 year
Our Promise to You
Why Participate?
Be part of something larger than yourself and help advance medicine for future generations. Also, you're condition may improve, and you'll get paid for your time.
Participating in a clinical trial is easy. Get to know our caring experts. Meet our team
Sign Up
Schedule Your Assessment
Sign up for an initial assessment (called a “prescreen”), and we'll give you a call. One of our professional medical staff will answer your questions and give you more information about Charter Research prior to an in-office visit.
Get More Information
Location supporting this study
-
Orlando
1724 N. Mills Avenue, Suite 200Orlando, FL 32803Hours of Operation
Monday thru Friday
8am to 5pm